Chile vs IDA blend: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Chile
- IDA blend
How they compare
Chile currently reports 26.7% against 11.5% in IDA blend, a difference of 15.2%.
That makes Chile's figure about 2.3 times IDA blend's.
Across all 9 years both countries report, Chile has been ahead every year.
Chile ranks 41st and IDA blend ranks 39th of 166 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.8% | 22.2% | 20.6% | Chile |
| 2010s | 35.0% | 16.8% | 18.2% | Chile |
| 2020s | 27.8% | 12.1% | 15.7% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Chile or IDA blend?
- Chile, at 26.7% against 11.5% in IDA blend as of 2024.
- What is the difference in prevalence of current tobacco use between Chile and IDA blend?
- 15.2%, with Chile ahead.
- How many years of comparable data are there for Chile and IDA blend?
- 9 years are reported by both, from 2000 to 2024.
- How do Chile and IDA blend rank globally for prevalence of current tobacco use?
- Chile ranks 41st and IDA blend ranks 39th of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.